GR862055B - Cephlosporin salts and injectable compositions - Google Patents

Cephlosporin salts and injectable compositions

Info

Publication number
GR862055B
GR862055B GR862055A GR860102055A GR862055B GR 862055 B GR862055 B GR 862055B GR 862055 A GR862055 A GR 862055A GR 860102055 A GR860102055 A GR 860102055A GR 862055 B GR862055 B GR 862055B
Authority
GR
Greece
Prior art keywords
cephlosporin
salts
injectable compositions
injectable
compositions
Prior art date
Application number
GR862055A
Other languages
Greek (el)
English (en)
Inventor
Kaplan A Murray
Hudyma W Thomas
Lipper A Robert
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of GR862055B publication Critical patent/GR862055B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
GR862055A 1985-08-05 1986-08-04 Cephlosporin salts and injectable compositions GR862055B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05

Publications (1)

Publication Number Publication Date
GR862055B true GR862055B (en) 1986-12-24

Family

ID=25064475

Family Applications (1)

Application Number Title Priority Date Filing Date
GR862055A GR862055B (en) 1985-08-05 1986-08-04 Cephlosporin salts and injectable compositions

Country Status (34)

Country Link
JP (1) JPH0615548B2 (fr)
KR (1) KR930003121B1 (fr)
AR (1) AR243894A1 (fr)
AT (1) AT390957B (fr)
AU (1) AU597262B2 (fr)
BE (1) BE905219A (fr)
CA (1) CA1284994C (fr)
CH (1) CH675581A5 (fr)
CS (2) CS276849B6 (fr)
CY (1) CY1614A (fr)
DD (2) DD254941A5 (fr)
DE (1) DE3626375A1 (fr)
DK (1) DK162053C (fr)
EG (1) EG18003A (fr)
ES (1) ES2002112A6 (fr)
FI (1) FI84484C (fr)
FR (1) FR2585705B1 (fr)
GB (1) GB2179936B (fr)
GR (1) GR862055B (fr)
HK (1) HK99691A (fr)
HU (1) HU196602B (fr)
IE (1) IE59222B1 (fr)
IL (1) IL79608A (fr)
IT (1) IT1197067B (fr)
LU (2) LU86540A1 (fr)
MY (1) MY102212A (fr)
NL (1) NL8601991A (fr)
OA (1) OA08672A (fr)
PT (1) PT83134B (fr)
SE (1) SE469633B (fr)
SG (1) SG79791G (fr)
SU (1) SU1516013A3 (fr)
YU (1) YU45793B (fr)
ZA (1) ZA865842B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988010263A1 (fr) * 1987-06-25 1988-12-29 Banyu Pharmaceutical Co., Ltd. Composes cristallins de cephalosporine, procede de preparation et produits intermediaires pour la preparation de ces composes
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
JPH02101081A (ja) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd セファロスポリン誘導体結晶性二塩酸塩及びその製造法
CA2011116C (fr) * 1989-03-06 1999-11-16 Murray A. Kaplan Dihydrochlorure de bmy-28142 lyophilise pour usage parenteral
CA2101571A1 (fr) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Dihydrate cristallise d'un sel de cephalosporine dihydrate; compositions injectables a base de ce compose
EP0638573A1 (fr) * 1993-08-10 1995-02-15 Lucky Ltd. Hydrates crystallins d'une céphalosporine et procédé pour leur préparation
CN100543027C (zh) 2003-12-23 2009-09-23 桑多斯有限公司 制备用于合成头孢菌素的中间体的方法
WO2008056221A2 (fr) * 2006-11-06 2008-05-15 Orchid Chemicals & Pharmaceuticals Limited Sel de sulfate cristallin d'antibiotique céphalosporine
DE102012101680A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
CA1213882A (fr) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporines
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3419015A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von cephalosporinen
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
ES2002112A6 (es) 1988-07-16
OA08672A (en) 1989-03-31
SE469633B (sv) 1993-08-09
GB8618989D0 (en) 1986-09-17
CA1284994C (fr) 1991-06-18
AR243894A1 (es) 1993-09-30
FI863155A0 (fi) 1986-08-01
CS276849B6 (en) 1992-08-12
DK371886D0 (da) 1986-08-04
SG79791G (en) 1991-11-15
HUT41802A (en) 1987-05-28
DK162053C (da) 1992-02-10
JPS62103090A (ja) 1987-05-13
IL79608A0 (en) 1986-11-30
YU137186A (en) 1987-12-31
CH675581A5 (fr) 1990-10-15
AT390957B (de) 1990-07-25
EG18003A (en) 1991-08-30
DD268395A5 (de) 1989-05-31
GB2179936A (en) 1987-03-18
JPH0615548B2 (ja) 1994-03-02
KR880002530A (ko) 1988-05-09
CY1614A (en) 1992-07-10
AU6069486A (en) 1987-02-12
NL8601991A (nl) 1987-03-02
AU597262B2 (en) 1990-05-31
SU1516013A3 (ru) 1989-10-15
IT1197067B (it) 1988-11-25
YU45793B (sh) 1992-07-20
IL79608A (en) 1991-07-18
CS276717B6 (en) 1992-08-12
DK162053B (da) 1991-09-09
MY102212A (en) 1992-05-15
FR2585705A1 (fr) 1987-02-06
SE8603308D0 (sv) 1986-08-04
IT8621409A1 (it) 1988-02-04
PT83134B (pt) 1989-07-31
IT8621409A0 (it) 1986-08-04
FI84484B (fi) 1991-08-30
BE905219A (fr) 1987-02-04
IE862078L (en) 1987-02-05
IE59222B1 (en) 1994-01-26
HK99691A (en) 1991-12-13
DD254941A5 (de) 1988-03-16
ATA211086A (de) 1990-01-15
KR930003121B1 (ko) 1993-04-19
SE8603308L (sv) 1987-02-06
LU86540A1 (fr) 1987-03-06
FR2585705B1 (fr) 1989-01-13
FI84484C (fi) 1991-12-10
PT83134A (en) 1986-09-01
ZA865842B (en) 1987-04-29
HU196602B (en) 1988-12-28
GB2179936B (en) 1989-04-26
DK371886A (da) 1987-02-06
LU88574I2 (fr) 1995-03-01
FI863155A (fi) 1987-02-06
DE3626375A1 (de) 1987-02-12

Similar Documents

Publication Publication Date Title
DE3666855D1 (en) Alcalisilicate compositions and their use
GB8621580D0 (en) Composition
GB8531635D0 (en) Composition
IL78934A0 (en) Alfuzosine compositions and use
GB2179338B (en) Composition
GB8508717D0 (en) Composition
GB8600767D0 (en) Composition
NZ216159A (en) Thiene derivatives and yield-promoting compositions
GB8524508D0 (en) Composition
GB8519452D0 (en) Injectable solutions
EP0214102A3 (en) 5-aralkyl-substituted 2h-benzotriazoles and stabilized compositions
GR862055B (en) Cephlosporin salts and injectable compositions
GB8629991D0 (en) Fat-desensitizing composition
GR861727B (en) 5-substituted-6-aminopyridine derivatives composition and uses
EP0230052A3 (en) Immunoamplifiers and related compositions
GB8604135D0 (en) Composition
EP0192630A3 (en) Aminomethylenephosphonate compositions
GB8514418D0 (en) Aminobenzylamine composition
PT83574A (en) Composition
EP0225309A3 (en) Aminomethylenephosphonate compositions
GB8606846D0 (en) Composition
GR860180B (en) Compositions and their use
IL88959A (en) Cephalosporin salts and injectable compositions
EG17458A (en) Fungicial compositions
GB8501527D0 (en) Composition